L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients.
作者信息
Goodwin F K, Murphy D L, Brodie H K, Bunney W E
出版信息
Biol Psychiatry. 1970 Oct;2(4):341-66.
PMID:4920729
Abstract
摘要
相似文献
1
L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients.左旋多巴、儿茶酚胺与行为：抑郁症患者的临床与生化研究
Biol Psychiatry. 1970 Oct;2(4):341-66.
2
L-dopa, behavioral activation and psychopathology.左旋多巴、行为激活与精神病理学
Res Publ Assoc Res Nerv Ment Dis. 1972;50:472-93.
3
[Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects].[帕金森综合征、抑郁或躁狂综合征患者通过灌注给予左旋多巴（联合或不联合脱羧酶抑制剂）时脑和外周左旋多巴摄取情况。药理作用]
Encephale. 1972 Mar-Apr;61(2):127-48.
4
Behavioral effects of l-dopa in man.左旋多巴对人体的行为影响。
Semin Psychiatry. 1971 Nov;3(4):477-92.
5
[10 years of L-DOPA therapy of Parkinson's syndrome].帕金森综合征的左旋多巴治疗十年
Wien Klin Wochenschr. 1971 Apr 2;83(13):221-7.
6
7
[Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].[左旋多巴与脱羧酶抑制剂（Ro 4-4602）治疗帕金森综合征。71例患者的病程]
Schweiz Med Wochenschr. 1972 Jan 22;102(3):88-94.
8
L-dopa, dopamine, and hypomania.左旋多巴、多巴胺与轻躁狂
Am J Psychiatry. 1973 Jan;130(1):79-82. doi: 10.1176/ajp.130.1.79.
9
[Effect of a decarboxylase inhibitor (Ro 4-4602) in combination with L-dopa on inhibited depressions].[一种脱羧酶抑制剂（Ro 4-4602）与左旋多巴联合使用对抑制性抑郁的作用]
Arzneimittelforschung. 1970 Jul;20(7):934-5.
引用本文的文献
1
Cabergoline associated with first episode mania.卡麦角林与首发躁狂症相关。
Psychosomatics. 2012 Nov-Dec;53(6):595-600. doi: 10.1016/j.psym.2012.01.005. Epub 2012 May 31.
2
Depression in Parkinson's disease: health risks, etiology, and treatment options.帕金森病中的抑郁：健康风险、病因和治疗选择。
Neuropsychiatr Dis Treat. 2008 Feb;4(1):81-91. doi: 10.2147/ndt.s1453.
3
Effects of an organophosphate (dichlorvos) on open field behavior and locomotor activity: correlation with regional brain monoamine levels.有机磷酸酯（敌敌畏）对旷场行为和运动活动的影响：与脑区单胺水平的相关性
Psychopharmacology (Berl). 1980;68(1):37-42. doi: 10.1007/BF00426647.
4
Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide.多巴胺与躁狂症：多巴胺受体阻滞剂匹莫齐特的行为及生化效应
Psychopharmacology (Berl). 1980;67(3):297-305. doi: 10.1007/BF00431272.
5
Antagonism of hypothermia and behavioral response to apomorphine: a simple, rapid and discriminating test for screening antidepressants and neuroleptics.低温拮抗作用及对阿扑吗啡的行为反应：一种用于筛选抗抑郁药和抗精神病药的简单、快速且有鉴别力的试验。
Psychopharmacology (Berl). 1981;75(1):84-91. doi: 10.1007/BF00433508.
6
Exploration of the anti-depressant potential of L-dopa.左旋多巴抗抑郁潜力的探索。
Psychopharmacologia. 1971;20(2):118-27. doi: 10.1007/BF00404366.
7
Amantadine-induced aggressiveness.金刚烷胺诱发的攻击性。
Br Med J. 1972 Jul 1;3(5817):50. doi: 10.1136/bmj.3.5817.50.
8
Catecholamines and memory: enhanced verbal learning during L-DOPA administration.儿茶酚胺与记忆：左旋多巴给药期间言语学习能力增强。
Psychopharmacologia. 1972;27(4):319-26. doi: 10.1007/BF00429385.
9
L-tryptophan in affective disorders: indoleamine changes and differential clinical effects.情感障碍中的L-色氨酸：吲哚胺变化及不同的临床效应。
Psychopharmacologia. 1974 Jan 9;34(1):11-20. doi: 10.1007/BF00421216.
10
Clinical use of psychotherapeutic drugs. I. Antipsychotic and antimanic drugs.精神治疗药物的临床应用。I. 抗精神病药和抗躁狂药。
Drugs. 1972;4(5):321-60. doi: 10.2165/00003495-197204050-00001.
Zotero 插件